Half the Placements Are LeasesNarrow moat
Intuitive Surgical (ISRG) — moat facet
Systems revenue has stopped being a demand signal, because the accounting choice moves it as much as the customer does.
The placement mix has crossed a threshold that changes how the company should be read.
Of 1,721 da Vinci systems placed in 2025, 376 went out under fixed-payment operating leases and 496 under usage-based operating leases — 872 in total, or 51% — plus a further 40 under sales-type leases1. Three years earlier the operating-lease share was 48%. In the June 2026 quarter it was 254 of 468, or 54%, of which 131 were usage-based2.
Intuitive has offered leasing since 2013 and describes the rationale plainly: it offers "customers flexibility in how they acquire systems and expand their robotic-assisted programs while leveraging our balance sheet", and the usage-based structures are aimed at "qualified customers that have committed da Vinci programs" where the company will "charge for the system and service as procedures are performed, offering greater predictability in costs for customers"3.
What it removes is the capital-approval bottleneck, which is the single most common reason a hospital does not proceed. What it adds, from Intuitive's side, is a longer, larger and more contingent revenue stream: fixed-payment leases cannot be exited without penalty, usage-based ones can.
There is a reporting consequence worth internalising. Because operating-lease revenue is recognised over time rather than upfront, systems revenue in any year reflects the mix as much as the demand. Intuitive attributes part of 2025's 26% systems revenue growth to "a decrease in the proportion of da Vinci surgical system placements under operating leases"4 — that is, to leasing less, not selling more.
Count placements, not systems revenue: 1,721 in 2025 and 468 in the June 2026 quarter. That is the number that says how fast the annuity base is growing.
Just over half of 2025 placements were leases, from a much smaller share three years ago. The trend has not reversed in any quarter.
Just over half. The mix shift is why a 26% rise in systems revenue can coexist with a placement number that barely moved, and why reported revenue has to be read alongside placements rather than instead of them.
- ReportedOf 1,721 da Vinci systems placed in 2025, 376 went out under fixed-payment operating leases and 496 under usage-based operating leases — 872 in total, or 51% — plus a further 40 under sales-type leases.Intuitive Surgical Form 10-K, fiscal year ended December 31, 2025 - Item 7 MD&A, results of operations (instruments and accessories $6,018.9M, systems $2,473.7M, service $1,572.1M, recurring revenue $8,465.3M, gross margin 66.0%, operating income $2,945.5M, average selling price, lease revenue recognition, and the discussion of procedure categories) — FY2025 · publ. February 3, 2026 · source ↗
- ReportedIn the June 2026 quarter it was 254 of 468, or 54%, of which 131 were usage-based.Intuitive Surgical Form 10-Q, quarter ended June 30, 2026 (installed base 11,710 da Vinci systems up 12%, 468 placements of which 246 were da Vinci 5, the operating-lease share, the distributor acquisitions in Italy, Spain and Portugal, cash and investments of $8.63 billion, and the factors expected to affect future placements) — Q2 2026 and the first six months · publ. July 21, 2026 · source ↗
- ReportedIntuitive has offered leasing since 2013 and describes the rationale plainly: it offers "customers flexibility in how they acquire systems and expand their robotic-assisted programs while leveraging our balance sheet", and the usage-based...Intuitive Surgical Form 10-K, fiscal year ended December 31, 2025 - Item 1 Business: competition, intellectual property and government regulation (the fourteen named competitors, more than 5,600 patents in force and 2,500 pending, Class II devices cleared under section 510(k) on substantial equivalence, special controls, field actions and recalls) — FY2025 · publ. February 3, 2026 · source ↗
- ReportedIntuitive attributes part of 2025's 26% systems revenue growth to "a decrease in the proportion of da Vinci surgical system placements under operating leases" — that is, to leasing less, not selling more.Intuitive Surgical Form 10-K, fiscal year ended December 31, 2025 - Item 7 MD&A, results of operations (instruments and accessories $6,018.9M, systems $2,473.7M, service $1,572.1M, recurring revenue $8,465.3M, gross margin 66.0%, operating income $2,945.5M, average selling price, lease revenue recognition, and the discussion of procedure categories) — FY2025 · publ. February 3, 2026 · source ↗